Release Date: 09/12/14 09:31 Summary: First Significant Revenue for Entellect Price Sensitive: Yes Download Document 246.28KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%